Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
![Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/generic/no-book-image.png)
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
by
Fujimoto, Junya
, Roth, Jack A
, Weissferdt, Annikka
, Allison, James P
, Antonoff, Mara B
, Jenq, Robert R
, Mehran, Reza J
, Skoulidis, Ferdinandos
, Bernatchez, Chantale
, Carter, Brett W
, Altan, Mehmet
, Francisco-Cruz, Alejandro
, Wargo, Jennifer A
, Fossella, Frank V
, Rice, David C
, Byers, Lauren Averett
, Swisher, Stephen G
, William, Jr, William N
, Wistuba, Ignacio I
, Dejima, Hitoshi
, Kurie, Jonathan M
, Heymach, John V
, Elamin, Yasir Y
, Tran, Hai T
, Kalhor, Neda
, Khan, Md Abdul Wadud
, Gibbons, Don L
, Blumenschein, Jr, George
, Walsh, Garrett L
, Reuben, Alexandre
, Lu, Charles
, Glisson, Bonnie S
, Haymaker, Cara
, Leung, Cheuk H
, Godoy, Myrna C B
, Hofstetter, Wayne L
, Sepesi, Boris
, Ajami, Nadim J
, Cascone, Tina
, Solis, Luisa M
, Tsao, Anne S
, Parra, Edwin R
, Federico, Lorenzo
, Sharma, Padmanee
, Futreal, Andrew
, Mott, Frank E
, Pataer, Apar
, Lin, Heather Y
, Vaporciyan, Ara A
, Lee, J Jack
, Kadara, Humam
, Zhang, Jianjun
, Le, Xiuning
in
Adult
/ Aged
/ Antineoplastic Combined Chemotherapy Protocols - administration & dosage
/ Biomarkers, Tumor - metabolism
/ Cancer therapies
/ Carcinoma, Non-Small-Cell Lung - drug therapy
/ Carcinoma, Non-Small-Cell Lung - metabolism
/ Chemotherapy
/ Drug therapy
/ Effector cells
/ Female
/ Humans
/ Immunological memory
/ Immunotherapy
/ Ipilimumab
/ Ipilimumab - administration & dosage
/ Lung cancer
/ Lung cancer, Non-small cell
/ Lung Neoplasms - drug therapy
/ Lung Neoplasms - metabolism
/ Lymphocytes
/ Lymphocytes T
/ Male
/ Memory cells
/ Metastases
/ Microenvironments
/ Middle Aged
/ Monoclonal antibodies
/ Neoadjuvant Therapy
/ Nivolumab - administration & dosage
/ Non-small cell lung carcinoma
/ Patients
/ Small cell lung carcinoma
/ Surgery
/ Targeted cancer therapy
/ Testing
/ Tumors
2021
![Hey, we have placed the reservation for you!](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-success.png)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
![Oops! Something went wrong.](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-fail.png)
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
![](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/generic/no-book-image.png)
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
by
Fujimoto, Junya
, Roth, Jack A
, Weissferdt, Annikka
, Allison, James P
, Antonoff, Mara B
, Jenq, Robert R
, Mehran, Reza J
, Skoulidis, Ferdinandos
, Bernatchez, Chantale
, Carter, Brett W
, Altan, Mehmet
, Francisco-Cruz, Alejandro
, Wargo, Jennifer A
, Fossella, Frank V
, Rice, David C
, Byers, Lauren Averett
, Swisher, Stephen G
, William, Jr, William N
, Wistuba, Ignacio I
, Dejima, Hitoshi
, Kurie, Jonathan M
, Heymach, John V
, Elamin, Yasir Y
, Tran, Hai T
, Kalhor, Neda
, Khan, Md Abdul Wadud
, Gibbons, Don L
, Blumenschein, Jr, George
, Walsh, Garrett L
, Reuben, Alexandre
, Lu, Charles
, Glisson, Bonnie S
, Haymaker, Cara
, Leung, Cheuk H
, Godoy, Myrna C B
, Hofstetter, Wayne L
, Sepesi, Boris
, Ajami, Nadim J
, Cascone, Tina
, Solis, Luisa M
, Tsao, Anne S
, Parra, Edwin R
, Federico, Lorenzo
, Sharma, Padmanee
, Futreal, Andrew
, Mott, Frank E
, Pataer, Apar
, Lin, Heather Y
, Vaporciyan, Ara A
, Lee, J Jack
, Kadara, Humam
, Zhang, Jianjun
, Le, Xiuning
in
Adult
/ Aged
/ Antineoplastic Combined Chemotherapy Protocols - administration & dosage
/ Biomarkers, Tumor - metabolism
/ Cancer therapies
/ Carcinoma, Non-Small-Cell Lung - drug therapy
/ Carcinoma, Non-Small-Cell Lung - metabolism
/ Chemotherapy
/ Drug therapy
/ Effector cells
/ Female
/ Humans
/ Immunological memory
/ Immunotherapy
/ Ipilimumab
/ Ipilimumab - administration & dosage
/ Lung cancer
/ Lung cancer, Non-small cell
/ Lung Neoplasms - drug therapy
/ Lung Neoplasms - metabolism
/ Lymphocytes
/ Lymphocytes T
/ Male
/ Memory cells
/ Metastases
/ Microenvironments
/ Middle Aged
/ Monoclonal antibodies
/ Neoadjuvant Therapy
/ Nivolumab - administration & dosage
/ Non-small cell lung carcinoma
/ Patients
/ Small cell lung carcinoma
/ Surgery
/ Targeted cancer therapy
/ Testing
/ Tumors
2021
![Oops! Something went wrong.](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-fail.png)
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
![Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/generic/no-book-image.png)
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
by
Fujimoto, Junya
, Roth, Jack A
, Weissferdt, Annikka
, Allison, James P
, Antonoff, Mara B
, Jenq, Robert R
, Mehran, Reza J
, Skoulidis, Ferdinandos
, Bernatchez, Chantale
, Carter, Brett W
, Altan, Mehmet
, Francisco-Cruz, Alejandro
, Wargo, Jennifer A
, Fossella, Frank V
, Rice, David C
, Byers, Lauren Averett
, Swisher, Stephen G
, William, Jr, William N
, Wistuba, Ignacio I
, Dejima, Hitoshi
, Kurie, Jonathan M
, Heymach, John V
, Elamin, Yasir Y
, Tran, Hai T
, Kalhor, Neda
, Khan, Md Abdul Wadud
, Gibbons, Don L
, Blumenschein, Jr, George
, Walsh, Garrett L
, Reuben, Alexandre
, Lu, Charles
, Glisson, Bonnie S
, Haymaker, Cara
, Leung, Cheuk H
, Godoy, Myrna C B
, Hofstetter, Wayne L
, Sepesi, Boris
, Ajami, Nadim J
, Cascone, Tina
, Solis, Luisa M
, Tsao, Anne S
, Parra, Edwin R
, Federico, Lorenzo
, Sharma, Padmanee
, Futreal, Andrew
, Mott, Frank E
, Pataer, Apar
, Lin, Heather Y
, Vaporciyan, Ara A
, Lee, J Jack
, Kadara, Humam
, Zhang, Jianjun
, Le, Xiuning
in
Adult
/ Aged
/ Antineoplastic Combined Chemotherapy Protocols - administration & dosage
/ Biomarkers, Tumor - metabolism
/ Cancer therapies
/ Carcinoma, Non-Small-Cell Lung - drug therapy
/ Carcinoma, Non-Small-Cell Lung - metabolism
/ Chemotherapy
/ Drug therapy
/ Effector cells
/ Female
/ Humans
/ Immunological memory
/ Immunotherapy
/ Ipilimumab
/ Ipilimumab - administration & dosage
/ Lung cancer
/ Lung cancer, Non-small cell
/ Lung Neoplasms - drug therapy
/ Lung Neoplasms - metabolism
/ Lymphocytes
/ Lymphocytes T
/ Male
/ Memory cells
/ Metastases
/ Microenvironments
/ Middle Aged
/ Monoclonal antibodies
/ Neoadjuvant Therapy
/ Nivolumab - administration & dosage
/ Non-small cell lung carcinoma
/ Patients
/ Small cell lung carcinoma
/ Surgery
/ Targeted cancer therapy
/ Testing
/ Tumors
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
![We have requested the book for you!](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-success.png)
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
![Oops! Something went wrong.](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-fail.png)
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
![Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial](https://syndetics.com/index.aspx?isbn=/mc.gif&issn=1078-8956&client=MBRL&type=mbrl)
Journal Article
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
2021
Request now
and choose the collection method
Overview
Ipilimumab improves clinical outcomes when combined with nivolumab in metastatic non-small cell lung cancer (NSCLC), but its efficacy and impact on the immune microenvironment in operable NSCLC remain unclear. We report the results of the phase 2 randomized NEOSTAR trial (NCT03158129) of neoadjuvant nivolumab or nivolumab + ipilimumab followed by surgery in 44 patients with operable NSCLC, using major pathologic response (MPR) as the primary endpoint. The MPR rate for each treatment arm was tested against historical controls of neoadjuvant chemotherapy. The nivolumab + ipilimumab arm met the prespecified primary endpoint threshold of 6 MPRs in 21 patients, achieving a 38% MPR rate (8/21). We observed a 22% MPR rate (5/23) in the nivolumab arm. In 37 patients resected on trial, nivolumab and nivolumab + ipilimumab produced MPR rates of 24% (5/21) and 50% (8/16), respectively. Compared with nivolumab, nivolumab + ipilimumab resulted in higher pathologic complete response rates (10% versus 38%), less viable tumor (median 50% versus 9%), and greater frequencies of effector, tissue-resident memory and effector memory T cells. Increased abundance of gut Ruminococcus and Akkermansia spp. was associated with MPR to dual therapy. Our data indicate that neoadjuvant nivolumab + ipilimumab-based therapy enhances pathologic responses, tumor immune infiltrates and immunologic memory, and merits further investigation in operable NSCLC.
Publisher
Nature Publishing Group
Subject
/ Aged
/ Antineoplastic Combined Chemotherapy Protocols - administration & dosage
/ Biomarkers, Tumor - metabolism
/ Carcinoma, Non-Small-Cell Lung - drug therapy
/ Carcinoma, Non-Small-Cell Lung - metabolism
/ Female
/ Humans
/ Ipilimumab - administration & dosage
/ Lung Neoplasms - drug therapy
/ Male
/ Nivolumab - administration & dosage
/ Non-small cell lung carcinoma
/ Patients
/ Surgery
/ Testing
/ Tumors
This website uses cookies to ensure you get the best experience on our website.